Morepen Laboratories share news, announcements and annual reports
NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹125.58.
29 Oct: open ₹119.31, high ₹119.31, low ₹119.31
- Under NSE's long-term additional surveillance, stage IV, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,538 Cr1,108th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.67
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.73
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.17%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.22
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 9,00,028
Morepen Laboratories share news and announcements
606 announcements, routine notices left out, newest first. Page 4 of 13.
Aug 2024
5 Aug · Committee Meeting Updates
5 Aug · Committee Meeting Updates
1 Aug · Committee Meeting Updates
1 Aug · Updates
May 2024
21 May · Results
17 May · Analysts
14 May · Board meeting
Apr 2024
29 Apr · Management
Mar 2024
31 Mar · Management
31 Mar · Management
30 Mar · Management
1 Mar · Management
Feb 2024
22 Feb · Board meeting
19 Feb · Board meeting
Jan 2024
31 Jan · Results
24 Jan · Analysts
24 Jan · Board meeting
Dec 2023
1 Dec · Management
Nov 2023
30 Nov · Management
2 Nov · Results
Oct 2023
30 Oct · Analysts
26 Oct · Board meeting
Sep 2023
28 Sep · Meeting
19 Sep · Management
Aug 2023
14 Aug
14 Aug · Board meeting
5 Aug · Management
5 Aug · Results
Jul 2023
31 Jul · Management
29 Jul · Board meeting
May 2023
16 May · Results
9 May · Board meeting
Apr 2023
Mar 2023